Skip to main content
Monday, November 16, 2026Nov 16

Jury deliberates for 4th day at Martin Shkreli’s fraud trial

Martin Shkreli arrives to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)
Martin Shkreli arrives to federal court in New York, Thursday, Aug. 3, 2017. Jurors are starting their fourth day of deliberations at the federal securities fraud trial of the former pharmaceutical company CEO. (AP Photo/Seth Wenig)

NEW YORK (AP) – Jurors are on their fourth day of deliberations at the securities fraud trial of former pharmaceutical company CEO Martin Shkreli (SHKREL’-ee).

Their work resumed Thursday in federal court in New York City.

Prosecutors say Shkreli looted his drug company to pay back investors in two failed hedge funds he ran. The defense says investors got their original investments back and even made hefty profits.

The former biotech CEO, nicknamed “Pharma Bro,” is best known for hiking up the price of a life-saving drug and for trolling his critics on social media.

If convicted of the most serious charges, he could face up to 20 years in prison but likely would receive far less time under sentencing guidelines.